LUNCH SYMPOSIUM Changing the Paradigm: Improving Outcomes of First Line HER2-Positive mBC with Trastuzumab Deruxtecan-based Treatment | Philippine Society of Medical Oncology

All Talks Registration

Login to Register

Talks

Day 1 REGISTRATION

Oct. 07
OPENING CEREMONIES INAUGURATION OF EXHIBITS PHOTO SESSION

Oct. 07
Transcending Generations of Medical Oncologists — From History-making to Making History

Oct. 07
TEA SYMPOSIUM Innovations in Supportive Oncology: From Liver Protection to Nutritional Recovery

Oct. 07
Cancer Care in 2035: Precision Oncology and Novel Drug Develop

Oct. 07
PM LUNCH BREAK

Oct. 07
From Clinical Evidence to Consultation Room: Optimizing Abemaciclib Therapy in High-Risk Early and Advanced HR+/HER2- Breast Cancer

Oct. 07
PLENARY SESSION 1.1 :Cancer Genomics Beyond the Basics

Oct. 07
PLENARY SESSION 1.2 Tumor Microenvironment & Immunologic Escape

Oct. 07
BOOTH EXHIBIT AND RESEARCH POSTER VISIT

Oct. 07

LUNCH SYMPOSIUM Changing the Paradigm: Improving Outcomes of First Line HER2-Positive mBC with Trastuzumab Deruxtecan-based Treatment

10/9/26, 12:45 PM - 10/9/26, 1:45 PM (Asia/Manila) (1 hour)

Speaker: Samuel Ow, MD
Sponsor: AstraZeneca